Corporate, Securities, And Governance

This is a supplemental presentation for this session.

Experienced merger-and-acquisition practitioners will discuss critical terms in cross-border deals, including practical aspects of multijurisdictional deals and key differences between US and European law. The panel will discuss empirical data on selected deal terms, such as insurance solutions, indemnification caps, baskets, escrows, and survival periods; different structural approaches such as "lockbox" transactions; metrics of purchase price adjustments; and other terms. For example, many cross-border deals contain material adverse change clauses that have a clear meaning under Delaware law in the United States, but their application in Europe is less clear. The panel will discuss differences in various deal terms that are not always fully appreciated given the convergence in documenting cross-border deals as well as the increasing importance of insurance solutions in cross-border deals. The program is directed to those seeking a better understanding of such differences when advising executives or negotiating with foreign parties.

In this template/checklist members of the health law industry can track developments in their acquisition project, using the best due diligence practices.